Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients

The goal of this clinical trial is to find out if taking natural products green tea and quercetin along with docetaxel chemotherapy improves the therapy of advanced prostate cancer, i.e., metastatic castration-resistant prostate cancer (mCRPC). It will also learn about the safety of this combination. Researchers will compare green tea plus quercetin to a placebo (a look-alike substance that contains no drug) in combination with docetaxel to see if green tea and quercetin works to improve the therapeutic effect of docetaxel.

Trial Details

NCT ID
NCT06615752
Phase
PHASE1 / PHASE2
Sponsor
Charles Drew University of Medicine and Science
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • green tea and quercetin + docetaxel
  • Placebo + docetaxel
Locations (sample)
  • Los Angeles, California, United States|34.05223,-118.24368

Key Eligibility Criteria

  • Signed and dated informed consent form and HIPPA (Health Insurance Portability and Accountability Act) authorization.
  • Stated willingness to comply with all study procedures and availability for the duration of the study.
  • Male patients 18 years or older
  • Diagnosed with metastatic prostate cancer

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →